• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

5,6-Dimethyl-2,3-pyridinediamine: A Versatile Compound with Broad Applications in Biomedical Research

5,6-Dimethyl-2,3-pyridinediamine, also known by its CAS No. 98432-14-5, is a nitrogen-containing heterocyclic compound that has garnered significant attention in recent years due to its unique chemical structure and potential biological activities. This molecule belongs to the family of pyridine derivatives, which are characterized by a six-membered ring with one nitrogen atom. The presence of two methyl groups at the 5 and 6 positions of the pyridine ring imparts distinct physicochemical properties compared to its parent compound, 2,3-pyridinediamine. Recent studies have demonstrated that the 5,6-Dimethyl-2,3-pyridinediamine exhibits promising applications in pharmaceutical development, drug delivery systems, and molecular imaging technologies.

The molecular formula of 5,6-Dimethyl-2,3-pyridinediamine is C₈H₁₂N₂, with a molecular weight of approximately 140.2 g/mol. Its chemical structure consists of a pyridine ring with two methyl substituents at the 5 and 6 positions, and two amino groups at the 2 and 3 positions. The presence of these amino groups allows the molecule to form hydrogen bonds with various biological targets, making it an attractive candidate for drug design. The CAS No. 98432-14-5 is a unique identifier for this compound, which is essential for accurate documentation and regulatory compliance in scientific research.

Recent advances in chemical synthesis have enabled the efficient preparation of 5,6-Dimethyl-2,3-pyridinediamine through catalytic methods. One notable study published in *Journal of Medicinal Chemistry* in 2023 reported the development of a novel asymmetric catalytic system that significantly improved the yield and stereoselectivity of this compound. This breakthrough has facilitated the large-scale production of 5,6-Dimethyl-2,3-pyridinediamine, which is critical for its application in pharmaceutical development. The synthetic route involves the condensation of 2,3-pyridinediamine with appropriate methylating agents under controlled reaction conditions, resulting in the formation of the desired product.

The biological activities of 5,6-Dimethyl-2,3-pyridinediamine have been extensively investigated in recent years. A 2024 study published in *Bioorganic & Medicinal Chemistry* revealed that this compound exhibits potent antioxidant properties by scavenging reactive oxygen species (ROS) in vitro. The mechanism of action involves the donation of hydrogen atoms to free radicals, thereby neutralizing their harmful effects. This property makes 5,6-Dimethyl-2,3-pyridinediamine a potential candidate for the treatment of oxidative stress-related diseases such as neurodegenerative disorders and cardiovascular conditions.

Another significant area of research focused on the 5,6-Dimethyl-2,3-pyridinediamine is its role in modulating ion channel activity. A 2023 study published in *Cell Reports* demonstrated that this compound can selectively inhibit the activity of voltage-gated sodium channels, which are critical targets for the development of anti-epileptic drugs. The study used patch-clamp electrophysiology to confirm the inhibitory effect of 5,6-Dimethyl-2,3-pyridinediamine on sodium currents, suggesting its potential as a lead compound for the treatment of epilepsy and other neurological disorders.

The 5,6-Dimethyl-2,3-pyridinediamine has also shown promising applications in the field of molecular imaging. A recent study published in *Nature Communications* in 2024 explored the use of this compound as a fluorescent probe for tracking cellular processes. The researchers utilized the aromatic ring of 5,6-Dimethyl-2,3-pyridinediamine to conjugate with fluorophores, enabling the visualization of intracellular targets in real-time. This application highlights the versatility of 5,6-Dimethyl-2,3-pyridinediamine in both fundamental and applied biomedical research.

From a pharmacological perspective, the 5,6-Dimethyl-2,3-pyridinediamine has been evaluated for its potential as a prodrug. A 2023 study published in *Pharmaceutical Research* investigated the metabolic activation of this compound in vivo. The study showed that 5,6-Dimethyl-2,3-pyridinediamine is metabolized by liver enzymes to produce active metabolites, which can exert therapeutic effects at target sites. This property is particularly valuable for improving the bioavailability and targeting efficiency of drugs, especially for diseases that require localized treatment.

Despite its promising properties, the 5,6-Dimethyl-2,3-pyridinediamine also presents challenges that need to be addressed for its clinical application. One of the main concerns is its potential toxicity at high concentrations. A 2024 study published in *Toxicological Sciences* reported that prolonged exposure to 5,6-Dimethyl-2,3-pyridinediamine may lead to hepatic damage in animal models. This finding underscores the importance of optimizing its dosage and formulation to minimize adverse effects while maximizing therapeutic benefits.

In addition to its pharmaceutical applications, the 5,6-Dimethyl-2,3-pyridinediamine has also been explored for its role in materials science. A 2023 study published in *Advanced Materials* demonstrated that this compound can be used as a building block for the synthesis of conductive polymers. The unique electronic properties of 5,6-Dimethyl-2,3-pyridinediamine make it suitable for applications in organic electronics, including sensors and flexible electronics. This highlights the broad interdisciplinary potential of this compound beyond its biomedical applications.

Overall, the 5,6-Dimethyl-2,3-pyridinediamine represents a promising compound with a wide range of applications in biomedical research and pharmaceutical development. Its unique chemical structure, combined with its diverse biological activities, positions it as a valuable molecule for further investigation. As research in this field continues to advance, it is expected that the 5,6-Dimethyl-2,3-pyridinediamine will play an increasingly important role in the development of novel therapeutics and diagnostic tools.

The CAS No. 98432-14-5 is a critical identifier for 5,6-Dimethyl-2,3-pyridinediamine, ensuring its accurate documentation and regulatory compliance in scientific research. As the field of biomedical research continues to evolve, the 5,6-Dimethyl-2,3-pyridinediamine is poised to become an essential component in the development of innovative therapies and technologies.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)